Maternal and neonatal response to COVID-19
The risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to maternal and newborn health has yet to be determined. Several reports suggest pregnancy does not typically increase the severity of maternal disease: however, cases of preeclampsia and preterm birth have been infrequently re...
Gespeichert in:
Veröffentlicht in: | American journal of physiology: endocrinology and metabolism 2020-08, Vol.319 (2), p.E315-E319 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to maternal and newborn health has yet to be determined. Several reports suggest pregnancy does not typically increase the severity of maternal disease: however, cases of preeclampsia and preterm birth have been infrequently reported. Reports of placental infection and vertical transmission are rare. Interestingly, despite lack of SARS-CoV-2 placenta infection, there are several reports of significant abnormalities in placenta morphology. Continued research on pregnant women infected with SiRS-CoV-2 and their offspring is vitally important. |
---|---|
ISSN: | 0193-1849 1522-1555 |
DOI: | 10.1152/ajpendo.00287.2020 |